Also re-: cannatrek Key growth figures: Over the past two years, Cannatrek has experienced rapid growth across all key measures including revenue, profit and its customer base.This includes the more than doubling of revenues across the 2022 ($42m audited) and 2023 ($89m unaudited) financial years More than two years of consecutive monthly profitsUnits sold in FY23 936k (almost 1M) (previous year 418k – almost 500k)
- Forums
- ASX - By Stock
- ECS
- Soap Box
Soap Box, page-81
Featured News
Add ECS (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.8¢ |
Change
0.001(5.88%) |
Mkt cap ! $23.19M |
Open | High | Low | Value | Volume |
1.8¢ | 2.0¢ | 1.8¢ | $67.48K | 3.651M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 172556 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 120981 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 172556 | 0.018 |
5 | 1650000 | 0.017 |
5 | 1500090 | 0.016 |
6 | 2562000 | 0.015 |
6 | 1057497 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 120981 | 2 |
0.020 | 260500 | 4 |
0.021 | 1356866 | 5 |
0.022 | 1669000 | 5 |
0.023 | 586913 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
ECS (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online